On November 5, the project titled "A Safety and Feasibility Exploratory Study of SCS Combined with Non-Invasive Brain-Controlled Hybrid Exoskeleton Training for the Treatment of Lower Limb Motor Impairment in Chronic Stroke" completed its filing with the National Health Commission for clinical research on new biomedical technologies. This marks the first non-invasive brain-computer interface clinical research project in China to complete filing since the implementation of the "Regulations on the Administration of Clinical Research and Translational Application of New Biomedical Technologies" in May 2026, signaling that China's cutting-edge non-invasive brain-computer interface technology has entered a new stage of standardized clinical research. The core equipment of the project is "Shengong-Shenchi," the world's first high-performance composite neural modulation rehabilitation system integrating brain, machine, spine, and body. Led by the team at the Brain-Computer Haihe Laboratory, the system is primarily used for neurorehabilitation intervention in patients in the plateau phase of lower limb motor impairment following chronic stroke.